JP2013529080A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529080A5
JP2013529080A5 JP2013510643A JP2013510643A JP2013529080A5 JP 2013529080 A5 JP2013529080 A5 JP 2013529080A5 JP 2013510643 A JP2013510643 A JP 2013510643A JP 2013510643 A JP2013510643 A JP 2013510643A JP 2013529080 A5 JP2013529080 A5 JP 2013529080A5
Authority
JP
Japan
Prior art keywords
dom7h
seq
variant
variable domain
single variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013510643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529080A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/058298 external-priority patent/WO2011144751A1/en
Publication of JP2013529080A publication Critical patent/JP2013529080A/ja
Publication of JP2013529080A5 publication Critical patent/JP2013529080A5/ja
Pending legal-status Critical Current

Links

JP2013510643A 2010-05-20 2011-05-20 改良された抗血清アルブミン結合変異体 Pending JP2013529080A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34651910P 2010-05-20 2010-05-20
US61/346,519 2010-05-20
PCT/EP2011/058298 WO2011144751A1 (en) 2010-05-20 2011-05-20 Improved anti-serum albumin binding variants

Publications (2)

Publication Number Publication Date
JP2013529080A JP2013529080A (ja) 2013-07-18
JP2013529080A5 true JP2013529080A5 (https=) 2014-07-03

Family

ID=44352234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013510643A Pending JP2013529080A (ja) 2010-05-20 2011-05-20 改良された抗血清アルブミン結合変異体

Country Status (13)

Country Link
US (2) US9040668B2 (https=)
EP (1) EP2571900A1 (https=)
JP (1) JP2013529080A (https=)
KR (1) KR20130109977A (https=)
CN (1) CN103003303A (https=)
AU (1) AU2011254559B2 (https=)
BR (1) BR112012029280A2 (https=)
CA (1) CA2799633A1 (https=)
EA (1) EA201291009A1 (https=)
IL (1) IL222802A0 (https=)
MX (1) MX2012013406A (https=)
SG (1) SG185437A1 (https=)
WO (1) WO2011144751A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
HK1211232A1 (en) 2012-12-21 2016-05-20 Sanofi Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
TW201609799A (zh) 2013-12-13 2016-03-16 賽諾菲公司 雙重glp-1/gip受體促效劑
EP3080152A1 (en) 2013-12-13 2016-10-19 Sanofi Non-acylated exendin-4 peptide analogues
WO2015086728A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
AR105284A1 (es) 2015-07-10 2017-09-20 Sanofi Sa Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
CN115925919A (zh) * 2015-11-13 2023-04-07 埃博灵克斯股份有限公司 改进的血清白蛋白结合免疫球蛋白可变结构域
KR20230074598A (ko) 2016-05-18 2023-05-30 모더나티엑스, 인크. 릴랙신을 인코딩하는 폴리뉴클레오타이드
JP2026506075A (ja) 2023-02-17 2026-02-20 アブリンクス エン.ヴェー. 新生児型fc受容体に結合するポリペプチド
WO2025021183A1 (zh) * 2023-07-27 2025-01-30 上海复宏汉霖生物医药有限公司 编码促肾上腺皮质激素的多核苷酸及其相关组合物和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
US9321832B2 (en) * 2002-06-28 2016-04-26 Domantis Limited Ligand
ES2263984T3 (es) 2002-06-28 2006-12-16 Domantis Limited Ligandos doble-especificos con una vida media serica aumentada.
PL1737962T3 (pl) 2004-03-24 2011-02-28 Domantis Ltd Uniwersalny lider GAS1
EA012622B1 (ru) 2004-06-01 2009-10-30 Домэнтис Лимитед Биспецифичные гибридные антитела с увеличенным периодом полувыведения из сыворотки
CA2589800A1 (en) 2004-12-02 2006-06-08 Domantis Limited Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
WO2007085814A1 (en) 2006-01-24 2007-08-02 Domantis Limited Fusion proteins that contain natural junctions
CA2688433A1 (en) * 2007-06-06 2008-12-11 Domantis Limited Methods for selecting protease resistant polypeptides
GB0724331D0 (en) * 2007-12-13 2008-01-23 Domantis Ltd Compositions for pulmonary delivery
WO2008149147A2 (en) * 2007-06-06 2008-12-11 Domantis Limited Polypeptides, antibody variable domains and antagonists
AU2008328726B2 (en) 2007-11-30 2014-06-12 Glaxo Group Limited Antigen-binding constructs
CN102405236A (zh) * 2009-02-19 2012-04-04 葛兰素集团有限公司 改进的抗-tnfr1多肽,抗体可变结构域和拮抗剂
SG173488A1 (en) * 2009-02-19 2011-09-29 Glaxo Group Ltd Improved anti-serum albumin binding variants
CA2767752C (en) * 2009-02-19 2020-07-07 Glaxo Group Limited Improved anti-serum albumin binding variants
EP2411054A2 (en) 2009-03-27 2012-02-01 Glaxo Group Limited Drug fusions and conjugates
EP2453920A2 (en) 2009-07-16 2012-05-23 Glaxo Group Limited Antagonists, uses & methods for partially inhibiting tnfr1
MX2012003939A (es) * 2009-09-30 2012-07-30 Glaxo Group Ltd Fusiones y conjugados de farmaco.

Similar Documents

Publication Publication Date Title
JP2013529080A5 (https=)
JP7840836B2 (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
CN110049997B (zh) 改进的血清白蛋白结合免疫球蛋白单可变结构域
CN103619878B (zh) 结合血清白蛋白的蛋白
JP2009545319A5 (https=)
JP2013538566A5 (https=)
JP2014513953A5 (https=)
IL267894B2 (en) Improved serum albumin binding agents
IL267897B2 (en) Improved serum albumin binders
JP2010502183A5 (https=)
JP2017500018A5 (https=)
CN108473564A (zh) 改进的血清白蛋白结合剂
CN101611056A (zh) 能够结合于血清蛋白的肽
JP2018526989A5 (https=)
CN115397852B (zh) 工程化抗il-2抗体
JP2009539349A5 (https=)
CN102781959A (zh) 能够结合血清白蛋白的肽和包含所述肽的化合物、构建体和多肽
JP2010533498A5 (https=)
JP2020521458A5 (https=)
JP2018113988A (ja) IL−1βへの結合メンバー
JP2010535032A5 (https=)
EA034854B1 (ru) Анти-il-17-антитела, способ их получения и способ применения
JP2015506945A5 (https=)
JP2013543384A5 (https=)
JP2018512124A5 (https=)